Amgen Book Value Per Share from 2010 to 2024

AMGN Stock  USD 277.37  3.43  1.25%   
Amgen Book Value Per Share yearly trend continues to be very stable with very little volatility. Book Value Per Share is likely to drop to 10.26. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Amgen Inc according to its financial statements. View All Fundamentals
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
11.64859813
Current Value
10.26
Quarterly Volatility
12.04277265
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 B, Interest Expense of 3 B or Selling General Administrative of 5.8 B, as well as many exotic indicators such as Price To Sales Ratio of 9.47, Dividend Yield of 0.0182 or PTB Ratio of 25.96. Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement Amgen's financial leverage analysis and stock options assessment as well as various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.

Latest Amgen's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Amgen Inc over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Amgen's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 11.64 X10 Years Trend
Slightly volatile
   Book Value Per Share   
       Timeline  

Amgen Book Value Per Share Regression Statistics

Arithmetic Mean20.80
Geometric Mean13.64
Coefficient Of Variation57.91
Mean Deviation9.98
Median18.91
Standard Deviation12.04
Sample Variance145.03
Range39.8542
R-Value(0.35)
Mean Square Error137.44
R-Squared0.12
Significance0.21
Slope(0.93)
Total Sum of Squares2,030

Amgen Book Value Per Share History

2024 10.26
2023 11.65
2022 6.8
2021 11.75
2020 16.06
2019 15.99
2018 18.91

Other Fundumenentals of Amgen Inc

Amgen Book Value Per Share component correlations

0.330.94-0.40.780.910.520.260.810.370.770.770.910.810.810.48-0.450.820.390.560.570.270.08-0.3
0.330.070.66-0.29-0.090.790.36-0.110.880.360.36-0.040.290.06-0.450.590.050.6-0.28-0.170.220.470.69
0.940.07-0.530.890.970.270.170.80.160.590.590.980.70.790.71-0.570.770.240.760.580.190.1-0.42
-0.40.66-0.53-0.82-0.70.330.11-0.760.62-0.43-0.43-0.63-0.47-0.52-0.590.95-0.570.34-0.46-0.480.040.60.94
0.78-0.290.89-0.820.96-0.04-0.040.84-0.230.530.530.950.640.710.78-0.810.73-0.010.760.620.08-0.2-0.73
0.91-0.090.97-0.70.960.180.110.890.010.630.630.980.710.810.72-0.720.810.150.720.660.18-0.11-0.61
0.520.790.270.33-0.040.180.50.220.890.610.610.160.510.41-0.40.330.450.52-0.090.240.420.350.42
0.260.360.170.11-0.040.110.50.050.470.320.320.030.20.26-0.180.090.130.18-0.10.060.860.050.12
0.81-0.110.8-0.760.840.890.220.05-0.050.760.760.820.710.790.54-0.80.850.210.430.70.13-0.4-0.72
0.370.880.160.62-0.230.010.890.47-0.050.260.260.030.20.11-0.40.610.110.56-0.120.070.40.560.68
0.770.360.59-0.430.530.630.610.320.760.261.00.570.920.750.03-0.450.810.270.120.40.22-0.23-0.33
0.770.360.59-0.430.530.630.610.320.760.261.00.570.920.750.03-0.450.810.270.120.40.22-0.23-0.33
0.91-0.040.98-0.630.950.980.160.030.820.030.570.570.70.770.75-0.650.770.160.790.580.090.03-0.52
0.810.290.7-0.470.640.710.510.20.710.20.920.920.70.740.16-0.440.780.150.370.310.070.0-0.28
0.810.060.79-0.520.710.810.410.260.790.110.750.750.770.740.51-0.620.950.30.560.60.24-0.04-0.48
0.48-0.450.71-0.590.780.72-0.4-0.180.54-0.40.030.030.750.160.51-0.690.420.010.810.46-0.03-0.04-0.63
-0.450.59-0.570.95-0.81-0.720.330.09-0.80.61-0.45-0.45-0.65-0.44-0.62-0.69-0.630.18-0.44-0.530.020.620.96
0.820.050.77-0.570.730.810.450.130.850.110.810.810.770.780.950.42-0.630.260.470.670.12-0.13-0.5
0.390.60.240.34-0.010.150.520.180.210.560.270.270.160.150.30.010.180.26-0.050.060.330.180.23
0.56-0.280.76-0.460.760.72-0.09-0.10.43-0.120.120.120.790.370.560.81-0.440.47-0.050.4-0.010.36-0.36
0.57-0.170.58-0.480.620.660.240.060.70.070.40.40.580.310.60.46-0.530.670.060.40.25-0.24-0.55
0.270.220.190.040.080.180.420.860.130.40.220.220.090.070.24-0.030.020.120.33-0.010.25-0.05-0.03
0.080.470.10.6-0.2-0.110.350.05-0.40.56-0.23-0.230.030.0-0.04-0.040.62-0.130.180.36-0.24-0.050.71
-0.30.69-0.420.94-0.73-0.610.420.12-0.720.68-0.33-0.33-0.52-0.28-0.48-0.630.96-0.50.23-0.36-0.55-0.030.71
Click cells to compare fundamentals

About Amgen Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amgen income statement, its balance sheet, and the statement of cash flows. Amgen investors use historical funamental indicators, such as Amgen's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Amgen investors may use each financial statement separately, they are all related. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amgen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amgen Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amgen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Book Value Per Share 11.65  10.26 
Tangible Book Value Per Share(84.18)(79.97)

Amgen Investors Sentiment

The influence of Amgen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amgen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amgen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amgen.

Amgen Implied Volatility

    
  116.55  
Amgen's implied volatility exposes the market's sentiment of Amgen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amgen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amgen stock will not fluctuate a lot when Amgen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.64EWTX Edgewise Therapeutics Financial Report 9th of May 2024 PairCorr

Moving against Amgen Stock

  0.75VKTX Viking TherapeuticsPairCorr
  0.75KRYS Krystal Biotech Financial Report 13th of May 2024 PairCorr
  0.72LLY Eli LillyPairCorr
  0.72HCWB HCW BiologicsPairCorr
  0.66OGN Organon Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.5
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.